Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Örjan Lindhe"'
Autor:
Markus Sällman Almén, Jonas Björk, Ulf Nyman, Veronica Lindström, Magnus Jonsson, Magnus Abrahamson, AnnaLotta Schiller Vestergren, Örjan Lindhe, Gary Franklin, Anders Christensson, Anders Grubb
Publikováno v:
Kidney International Reports, Vol 4, Iss 1, Pp 67-79 (2019)
Introduction: Shrunken pore syndrome (SPS), originally defined by cystatin C−based estimated glomerular filtration rate (eGFRcystatin C) being less than 60% of creatinine-based estimated glomerular filtration rate (eGFRcreatinine) in the absence of
Externí odkaz:
https://doaj.org/article/1aeb9e4edf704a6ebdd5be7db0b828f7
Autor:
Jesse, Huang, Mohsen, Khademi, Örjan, Lindhe, Gunn, Jönsson, Fredrik, Piehl, Tomas, Olsson, Ingrid, Kockum
Publikováno v:
Molecular & Cellular Proteomics : MCP
Proteomics studies are important for the discovery of new biomarkers as clinical tools for diagnosis and disease monitoring. However, preanalytical variations caused by differences in sample handling protocol pose challenges for assessing biomarker r
Autor:
Anders Grubb, Anders Christensson, Gary Franklin, Magnus Abrahamson, Markus Sällman Almén, Örjan Lindhe, Ulf Nyman, Magnus P. Jonsson, Jonas Björk, AnnaLotta Schiller Vestergren, Veronica Lindström
Publikováno v:
Kidney International Reports, Vol 4, Iss 1, Pp 67-79 (2019)
Kidney International Reports
Kidney International Reports
Introduction: Shrunken pore syndrome (SPS), originally defined by cystatin C−based estimated glomerular filtration rate (eGFRcystatin C) being less than 60% of creatinine-based estimated glomerular filtration rate (eGFRcreatinine) in the absence of
Publikováno v:
Proceedings of the National Academy of Sciences
Autor:
Per Almqvist, Dag Nilsson, Sven-Åke Gustafsson, Gunnar Antoni, Örjan Lindhe, Mats Bergström, Matts Kågedal
Publikováno v:
International Journal of Molecular Imaging. 2011:1-6
Zolmitriptan is a serotonin5-HT1B/1Dreceptor agonist that is an effective and well-tolerated drug for migraine treatment. In a human positron emission tomography study, [11C]zolmitriptan crossed the blood-brain barrier but no clear pattern of regiona
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 52:295-303
This work deals with radiochemistry and new approaches to develop novel PET tracers labelled with the radionuclide 11C.Two methods for the synthesis of 11C-labelled acrylamides have been explored. First, [1-11C]-acrylic acid was obtained from a palla
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 36:1453-1459
[(11)C]Acetate (C-AC) is a general PET tracer of cellular carbon flux and useful for clinical imaging in heart disease as well as prostate cancer and other tumours. C-AC has a high (70%) whole-body extraction fraction, proportional to blood flow in m
Autor:
Mikael Palner, Obaidur Rahman, Bengt Långström, Birgitte Rahbek Kornum, Örjan Lindhe, Stina Syvänen, Margareta Hammarlund-Udenaes, Gitte M. Knudsen
Publikováno v:
University of Copenhagen
Species differences occur in the brain concentrations of drugs, but the reasons for these differences are not yet apparent. This study was designed to compare brain uptake of three radiolabeled P-glycoprotein (P-gp) substrates across species using po
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 51:273-276
This thesis deals with the synthesis and development of 18F-labelled alkyl etomidate and vorozole analogues, and their use as positron emission tomography (PET) tracers for the imaging of the steroid enzymes 11β-hydroxylase and aromatase. Two synthe
Publikováno v:
Archives of Toxicology. 82:159-163
The CYP11B1-activated adrenocortical toxicant 3-methylsulphonyl-DDE (3-MeSO2-DDE) is proposed as a lead compound for an improved chemotherapy for adrenocortical carcinoma. We compared the binding of 3-MeSO2-[14C]DDE in the adrenal cortex of four rode